11th ESNI Course 2011

2011 – 11th ESNI COURSE | Glasgow (UK) | 4-7 July

I Day

Neuroinflammation and cellular responses in the CNS

  • Banking the brain – from resource to laboratory (Sandra Amor)
  • Neuropathology now! (Hans Lassmann)
  • What’s really going on? Visualising neuroinflammation in vivo (Martin Kerschensteiner)
  • Strinking in Balance – Innate v adaptive immunity in neuroinflammation (Hugh Perry)

Genetics, Environment factors and neuroinflammation

  • Emerging genetics in MS: a numbers game. (Stephen Sawcer)
  • Gene-environment interactions In MS: triggers for disease induction (Tomas Olsson)
  • Where did it all start? Lessons from Lactose Intolerance (Mark Thomas)

II Day

Disease Mechanisms and Treatment strategies 1

  • Neurodegeneration and immunity: an intimate relationship (Rudolf Martini)
  • Neuroprotective strategies for inflammatory CNS deseases (David Baker)
  • T cells and autoimmune homeostasis (Steve Anderton)
  • Sphingosine-1-phosphate pathways: therapeutic targets in autoimmune disease (Anna Schubart)

Disease Mechanisms and Treatment strategies 2

  • B cell dependent mechanisms in neuroinflammatory diseases (Chris Linington)
  • Impact of immune re-education on CNS repair: lessons from alemtuzumab (Alasdair Coles)
  • Using the immune system to treat Alzheimer’s disease (James Nicoll)
  • Enviromental Factors – targets for preventative strategies in MS? (George Ebers)


Humoral effector mechanisisms in neurology

  • Autoantibodies in neurology: biomarkers to immunetherapeutic target (Chris Linington)
  • Channels and Receptors: critical targets in antibody mediated diseases (Angela Vincent)
  • Heteromeric lipid complexes: novel targets in neuroimmune disease. (Hugh Willison )
  • Neuromyelitis optica: from patient to model and back again. (Monika Bradl)

IV Day

Hinnate mechanisms and treatment strategies

  • FC Receptors in neuroinflammation (Jessica L. Teeling)
  • Macrophages, Polarisation and Function (Carl Goodyear)
  • Complement-based therapeutics in neurological diseases (Claire Harris)
  • High dose iv lg – mode of action and clinical applications (Hans-Peter Hartung)

Stem cells and neuroinflammatory disease

  • Glial cell transplantation strategies in the CNS. (Susan Barnett)
  • Neural Steam cell transplantation; a therapeutic option. (Gianvito Martino)
  • Hematopoietic stem cell transplantation – an emerging strategy in autoimmunity? (Paolo Muraro)
  • Mesenchymal stem cells: where we are, where we go (Antonio Uccelli)

Final Program